## Management of Sensitizing Events in Rh-Negative Pregnancy ### Definition of Sensitizing Event **Key Point:** Any event with potential for **fetal-maternal hemorrhage (FMH)** in an Rh-negative, unsensitized woman requires immediate anti-D prophylaxis. These include: - Antepartum hemorrhage (placenta previa, threatened abortion, abruption) - Invasive procedures (amniocentesis, CVS) - External cephalic version - Abdominal trauma - Ectopic pregnancy rupture ### Correct Approach: Administer Anti-D Immediately (500 IU), Then Quantify FMH **High-Yield:** Per RCOG Green-top Guideline No. 22 and standard obstetric practice (Williams Obstetrics, 25th ed.): 1. **Administer anti-D immunoglobulin 500 IU IM immediately** — do NOT wait for Kleihauer-Betke results 2. **Perform Kleihauer-Betke test** (or flow cytometry) within 2 hours of the sensitizing event to quantify FMH 3. **Administer additional anti-D** if FMH exceeds 4 mL fetal whole blood (i.e., >2.5 mL fetal RBCs), at 500 IU per 4 mL fetal blood ### Why 500 IU Fixed Dose — Not 100 IU/kg? **Clinical Pearl:** The **empiric initial dose** for a sensitizing event at ≥20 weeks gestation is **500 IU (250 mcg) fixed dose**, not a weight-based 100 IU/kg calculation. The 100 IU/kg formula is used when calculating **supplemental doses** after Kleihauer-Betke quantification reveals large FMH. Option C's "100 IU/kg immediately" conflates the supplemental dosing formula with the empiric initial dose — this is a critical distinction. ### Timing is Critical Anti-D must be given **within 72 hours** of the sensitizing event for maximum efficacy. Waiting for Kleihauer-Betke results before giving the initial dose risks sensitization — hence Option A is incorrect. ### Why Not Defer to Delivery (Option B)? Deferring anti-D until delivery allows sensitization to occur during pregnancy, when FMH risk is highest and the maternal immune response is most robust. The goal is **prevention**, not treatment. ### Why This Patient? | Feature | Significance | |---------|-------------| | **Vaginal bleeding at 24 weeks** | Sensitizing event — FMH risk | | **ICT negative** | Unsensitized; eligible for prophylaxis | | **Previous Rh+ babies** | Confirms ongoing risk of FMH | | **Prior anti-D post-delivery** | Does NOT provide protection in current pregnancy | **Warning:** Previous anti-D administration after a prior delivery does **not** provide ongoing protection in a subsequent pregnancy. Each pregnancy requires its own antenatal and event-based prophylaxis. ### Mnemonic: SAFE Approach **S** — Sensitizing event identified (antepartum hemorrhage) **A** — Anti-D given immediately (500 IU fixed dose) **F** — FMH quantified (Kleihauer-Betke after administration) **E** — Extra anti-D if needed (based on quantification result) **Reference:** RCOG Green-top Guideline No. 22 (2011); Williams Obstetrics 25th ed., Chapter 16.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.